Literature DB >> 7851016

Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis.

M J Palmen1, L A Dieleman, M B van der Ende, A Uyterlinde, A S Peña, S G Meuwissen, E P van Rees.   

Abstract

In rodents, intracolonic administration of ethanol 30% induces an acute colitis, while administration of 2,4,6-trinitrobenzene sulphonic acid (TNBS) in ethanol induces a longer lasting colitis. In the acute and chronic stages of experimental colitis, lymphoid and non-lymphoid cells were studied in the colon by immunohistochemistry. During the acute inflammation a high damage score of the colon was observed, which was related to an increase in the number of macrophages and granulocytes. Also a change in distributional patterns of macrophage subpopulations was found. The chronic stage of TNBS-ethanol-induced colitis was characterized by an increase in the number of lymphocytes, especially T cells. These data suggest that macrophages and granulocytes are important in the acute phase of experimental colitis, while lymphocytes play a pivotal role in the chronic stage. As most inflammatory bowel disease (IBD) patients have relapses during the chronic disease, we attempted to induce a relapse during experimental colitis by giving a second i.p. or s.c. dose of TNBS. This resulted in increased damage scores of the colon, new areas of ulceration and a further increase in macrophage numbers. No effect on the number of granulocytes was seen. These results indicate that it is possible to mimic relapses in experimental colitis by a second administration of TNBS, and suggest that the rats had been sensitized by the first dose of TNBS, given into the colon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851016      PMCID: PMC1534285          DOI: 10.1111/j.1365-2249.1995.tb05537.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Hapten-induced model of chronic inflammation and ulceration in the rat colon.

Authors:  G P Morris; P L Beck; M S Herridge; W T Depew; M R Szewczuk; J L Wallace
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

2.  Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes.

Authors:  G R Woollett; A N Barclay; M Puklavec; A F Williams
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

3.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen.

Authors:  W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

4.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

5.  The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells.

Authors:  M J Dallman; D W Mason; M Webb
Journal:  Eur J Immunol       Date:  1982-06       Impact factor: 5.532

6.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

7.  Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.

Authors:  S Kunin; R Gallily
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

8.  Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1.

Authors:  J G Damoiseaux; E A Döpp; W Calame; D Chao; G G MacPherson; C D Dijkstra
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

9.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  Evidence for function of Ia molecules on gut epithelial cells in man.

Authors:  L Mayer; R Shlien
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  16 in total

1.  Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.

Authors:  Nobuki Ichikawa; Kenichiro Yamashita; Tohru Funakoshi; Shin Ichihara; Moto Fukai; Masaomi Ogura; Nozomi Kobayashi; Masaaki Zaitsu; Tadashi Yoshida; Susumu Shibasaki; Yasuyuki Koshizuka; Yusuke Tsunetoshi; Masanori Sato; Takahiro Einama; Michitaka Ozaki; Kazuo Umezawa; Tomomi Suzuki; Satoru Todo
Journal:  Inflamm Res       Date:  2015-12-18       Impact factor: 4.575

2.  Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis.

Authors:  S A McDonald; M J Palmen; E P Van Rees; T T MacDonald
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

4.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.

Authors:  Md Hasan Zaki; Kelli L Boyd; Peter Vogel; Michael B Kastan; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

5.  Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.

Authors:  O L Wijburg; M H Heemskerk; A Sanders; C J Boog; N Van Rooijen
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

6.  Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitis.

Authors:  F Magro; S Fraga; I Azevedo; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

7.  Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats.

Authors:  M J Palmen; C D Dijkstra; M B van der Ende; A S Peña; E P van Rees
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats.

Authors:  M J Palmen; L A Dieleman; M Soesatyo; A S Peña; S G Meuwissen; E P van Rees
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.

Authors:  Lisiane B Meira; James M Bugni; Stephanie L Green; Chung-Wei Lee; Bo Pang; Diana Borenshtein; Barry H Rickman; Arlin B Rogers; Catherine A Moroski-Erkul; Jose L McFaline; David B Schauer; Peter C Dedon; James G Fox; Leona D Samson
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

10.  CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.

Authors:  M J Palmen; O L Wijburg; I H Kunst; H Kroes; E P van Rees
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.